Overview of Dr. Chan
Dr. Onyee Chan is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from University of Arizona College of Medicine - Phoenix and has been in practice 4 years. She is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 60 publications and over 500 citings.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2014 - 2017
University of Arizona College of Medicine - PhoenixClass of 2014, MD
Certifications & Licensure
FL State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 13 citationsChronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Neil P Shah, Ravi Bhatia, Jessica K Altman, Maria Amaya, Kebede H Begna
Journal of the National Comprehensive Cancer Network. 2024-02-01 - 44 citationsBaseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes.Anthony M. Hunter, Rami S. Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan
Blood Advances. 2021-02-23 - 6 citationsMYC overexpression is associated with an early disease progression from MDS to AML.David Gajzer, Constantine Logothetis, David A. Sallman, Gregoire Calon, Abida Babu
Leukemia Research. 2021-12-01
Abstracts/Posters
- OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid LeukemiaOnyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypomethylating Agent and Venetoclax Combination Yields Comparable Outcomes to CPX-351 in Newly Diagnosed Acute Myeloid LeukemiaOnyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients _70 Years with Acute M...Onyee Chan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- RUNX1 Mutation Is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia Receiving Allogeneic Stem Cell Transplantation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
